2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis

Conditions:   Moderate to Severe Plaque Psoriasis;   Psoriatic Arthritis;   Ankylosing Spondylitis;   Non-radiographic Axial Spondyloarthritis Intervention:   Other: secukinumab Sponsor:   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials